Healia Clinical Trials Information Database

Psychological Intervention in Stroke Recovery

The purpose of this trial is to assess the effects of a psychosocial intervention on functional recovery after stroke.

Description

Prior research shows that, after a stroke, emotional support from friends and family is very important in recovery from stroke. This study was designed to test whether a program of family sessions would lead to a faster recovery for stroke patients and lower stress for their families. The sessions were designed to mobilize the family and close friends of a stroke patient and help them to provide effective support to the patient. The aim of the study was to help patients who have recently had a stroke to achieve greater functional ability. Participants were randomly assigned to either the standard care or the treatment group. Those in the treatment group received standard care plus a maximum of 16 home-based sessions, or family meetings, with a specially-trained clinician. (The majority of participants received 14 or 15 sessions.) The sessions included stroke education, information about services and community resources, assistance with problem solving to aid in gaining independence, help with coping, and emotional support. The study is no longer enrolling patients and the study data has been collected. The data is now being analyzed.

Status: Completed (Phase 3).

Enrollment: 291 subjects

Study Type: Interventional

Study Design:

  • Prevention
  • Randomized

Conditions:

Interventions:

  • Procedure: home-based sessions/family meetings with trained clinician

Eligibility

Inclusion:

  • patients with ischemic stroke or non-traumatic intracerebral hemorrhage, with residual deficit origin;

  • age 45 or older

  • stroke severity (3-8 on the NIH stroke severity scale); and

  • able to participate in the intervention (due to, for example, ability to communicate or level of social connectedness).

Exclusion:

  • patients living outside the greater Boston area;

  • admitted from a nursing home;

  • terminally ill;

  • severely aphasic;

  • significantly cognitively impaired;

  • unable to speak English; and

  • under 45 years of age.

Gender

Both

Mininum Age

45 Years

Maximum Age

N/A

Healthy Volunteers

No


Resources

Source: National Institute of Neurological Disorders and Stroke (NINDS)

Authority: United States: Federal Government

Locations

  • Massachusetts General Hospital
    Boston
    Massachusetts
    02114
    United States
  • Brigham and Women’s Hospital
    Boston
    Massachusetts
    02115
    United States
  • Beth Israel Deaconess Medical Center
    Boston
    Massachusetts
    02215
    United States
  • Mount Auburn Hospital
    Cambridge
    Massachusetts
    02238
    United States
  • Spaulding Rehabilitation Hospital
    Boston
    Massachusetts
    02114
    United States
  • Youville Rehabilitation Hospital
    Cambridge
    Massachusetts
    02138
    United States

Officials

  • Lisa Berkman, PhD (Principal Investigator, Harvard School of Public Health, Department of Society, Human Development, and Health)

Sponsors

  • National Institute of Neurological Disorders and Stroke (NINDS) (Lead Sponsor)

References

None.

Links

None.


Date Verified
May 1st, 2007
First Received
May 21st, 2007
Last Changed
May 21st, 2007

Information obtained from ClinicalTrials.gov on July 15, 2008. Link to the current ClinicalTrials.gov record.


All data in the Healia Clinical Trials Information Database and content displayed by the Healia Clinical Trials Search Engine are licensed from the National Institutes of Health (National Library of Medicine), which collects and maintains the data.

The Healia Clinical Trials Search Engine searches the data set at clinicaltrials.gov, providing up-to-date information about current clinical trials. In the Healia Clinical Trials Database you can find information on new experimental drugs, medical devices, and other types of treatments for all types of diseases. Each clinical trial description includes information about the phase of the trial (phase I, phase II, or phase III), the trial’s methods, such as whether it is a randomized, placebo controlled, double blind study, and the status of the trial including whether or not the trial is currently enrolling new participants.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.